Tag

Telehealth

All articles tagged with #telehealth

Dissent Signals Fresh Front in Mifepristone Fight as Telehealth Access Survives
politics13 days ago

Dissent Signals Fresh Front in Mifepristone Fight as Telehealth Access Survives

The Supreme Court allowed the continued mailing and telehealth dispensing of mifepristone while the case plays out, but conservative Justices Thomas and Alito dissented, warning that enforcing the 1873 Comstock Act could threaten broader abortion access and hinting at a renewed federal abortion ban push. The decision preserves a critical lifeline for medication abortion in the near term, though advocates warn the threat to access remains tied to ongoing regulatory reviews, potential political maneuvering ahead of the midterms, and the Dobbs framework that eliminated a nationwide abortion right. Medication abortions already account for a large share of U.S. procedures, and while misoprostol-alone options exist, experts note they are less convenient and carry more side effects. This remains a high-stakes, politically charged battleground for abortion access.

Supreme Court Keeps Mail-Order Abortion Pill Accessible as Case Winds Through Courts
us-politics14 days ago

Supreme Court Keeps Mail-Order Abortion Pill Accessible as Case Winds Through Courts

The Supreme Court issued a brief order allowing the abortion pill mifepristone to continue to be prescribed via telehealth and mailed to patients, blocking a Fifth Circuit ruling while litigation continues in lower courts. The decision preserves access for now as Louisiana’s challenge to FDA rules proceeds, with justices Thomas and Alito dissenting; the case centers on whether the FDA’s loosened 2021 regulations were properly grounded amid ongoing safety reviews and regulatory scrutiny.

Supreme Court Keeps Abortion Pill Mailings Open During Louisiana Challenge
politics14 days ago

Supreme Court Keeps Abortion Pill Mailings Open During Louisiana Challenge

The Supreme Court blocked a lower-court order that would have halted mailing mifepristone, allowing telehealth prescriptions for the abortion pill to continue while Louisiana challenges its legality. Mailed access has contributed to rising telehealth abortions—about a quarter of all abortions and half of those in states with bans—amid ongoing legal fights that could reach the Court again, with dissents from Justices Thomas and Alito criticizing the decision.

SCOTUS Keeps Abortion Pill Access Open via Telehealth and Mail
politics14 days ago

SCOTUS Keeps Abortion Pill Access Open via Telehealth and Mail

The Supreme Court temporarily preserves access to the abortion pill mifepristone by allowing telehealth visits and mail distribution to continue, maintaining the status quo while Louisiana’s challenge proceeds in the federal courts; the court paused a May 1 ruling requiring in-person visits, Justices Thomas and Alito dissented, and the merits will likely be reviewed again in the appeals court before any final ruling.

Hims & Hers Slumps 10% After Q1 Miss, Regulators Scrutinize Telehealth Giant
business17 days ago

Hims & Hers Slumps 10% After Q1 Miss, Regulators Scrutinize Telehealth Giant

Hims & Hers Health posted first-quarter revenue of $608 million and a loss of $0.40 per share, missing expectations of $616.8 million and $0.03, which sent the stock down as much as 10% after hours. The company raised its full-year revenue guidance to about $2.8–3.0 billion from a prior range, with Q2 revenue seen around $2.7 billion by analysts. The results come amid regulatory scrutiny after a Wegovy-like rollout was pulled following a Novo Nordisk lawsuit, and ongoing GLP-1 drug partnerships with Novo Nordisk. Analysts maintain a Moderate Buy rating with a $28.02 price target, implying modest downside from current levels.

Supreme Court Keeps Abortion-Pill Access Open as Mifepristone Case Winds Through Court
politics17 days ago

Supreme Court Keeps Abortion-Pill Access Open as Mifepristone Case Winds Through Court

The Supreme Court on Monday extended a short-term stay allowing patients to continue obtaining the abortion pill mifepristone via telehealth visits and mail through Thursday at 5 p.m. ET, while it weighs an emergency appeal. The extension preserves access after the 5th Circuit had ordered in-person visits, a ruling that sparked chaos for providers. The case ties FDA policy on mifepristone to the broader Dobbs era of abortion politics, with Louisiana challenging the FDA and both Danco Laboratories and GenBioPro filing emergency appeals.

Providers map contingency plans to keep telehealth abortion after in-person mifepristone ruling
health23 days ago

Providers map contingency plans to keep telehealth abortion after in-person mifepristone ruling

After the 5th Circuit reinstated a requirement that mifepristone be dispensed in person, abortion-rights advocates warned telehealth access could falter. While that concern persists, many providers say they’ve prepared contingency plans—relying on in-person dispensing options where possible and adapting telehealth protocols—to preserve access as legal battles continue.

Supreme Court Keeps Abortion Pill Accessible Across Telehealth as Case Moves Forward
politics24 days ago

Supreme Court Keeps Abortion Pill Accessible Across Telehealth as Case Moves Forward

The Supreme Court temporarily blocked a ruling that would severely limit access to the abortion pill mifepristone, allowing it to be obtained via telehealth, mail, and pharmacies for now while the case proceeds. The order preserves one of the main pathways for medication abortions in the U.S. as parties prepare further arguments after a federal appeals court imposed new restrictions.

Supreme Court pauses abortion-pill access limits during emergency review
politics25 days ago

Supreme Court pauses abortion-pill access limits during emergency review

The Supreme Court issued an administrative stay Monday that preserves telehealth and mail access to the abortion pill mifepristone for now, keeping the current status quo through May 11 while emergency appeals from the drugmakers are reviewed after a Fifth Circuit ruling requiring in-person pickup. It’s not a final decision, but it delays a nationwide shift that could have restricted access as the justices reconsider FDA rules and related state bans amid broader abortion-rights changes.

Court Restores In-Person Rule for Abortion Pill Nationwide
politics27 days ago

Court Restores In-Person Rule for Abortion Pill Nationwide

A federal appeals court temporarily reinstated a nationwide in-person dispensing rule for the abortion pill, limiting telehealth access that had expanded after Dobbs. Louisiana had challenged the FDA’s rules, arguing the regulations allow out-of-state prescribers to bypass state bans. The Fifth Circuit’s decision marks a significant development in the ongoing legal fight over mifepristone access and safety amid the broader abortion rights debate.

The Testosterone Tipping Point: TRT Use Surges Amid Telehealth Boom
health1 month ago

The Testosterone Tipping Point: TRT Use Surges Amid Telehealth Boom

A surge in testosterone replacement therapy (TRT) driven by the telehealth boom is making it easier for men to obtain high-dose regimens, often with limited cardiovascular screening. Doctors warn that many patients seek elevated levels rather than treating deficiencies, raising risks such as thickened blood, mood changes, and fertility issues. While FDA advisers consider loosening restrictions to improve access for those with low testosterone, experts caution against abuse and stress that TRT is not a magic pill—set against a backdrop of declining average testosterone and broader public‑health concerns about safety and monitoring.